HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Chinese aspirin

This article was originally published in The Tan Sheet

Executive Summary

International Trade Administration postpones preliminary determination on Chinese aspirin "dumping" until Dec. 21. The Commerce Department announced the bulk aspirin antidumping duty investigation in June, with a preliminary determination due by Nov. 4. ITA delayed its preliminary findings at the request of Cranbury, N.J.-based bulk aspirin manufacturer Rhodia, a Rhone-Poulenc S.A. subsidiary, which is seeking the imposition of antidumping duties on bulk aspirin imports from the People's Republic of China (1"The Tan Sheet" June 14, p. 9)

You may also be interested in...

Chinese Aspirin "Dumping" Is Under Trade Commission Investigation

The International Trade Commission is instituting an investigation into evidence of possible Chinese aspirin "dumping" onto the U.S. market, the commission announced in the Federal Register June 7. The investigation follows a May 28 petition from bulk aspirin manufacturer Rhodia requesting the "imposition of antidumping duties on imports of bulk aspirin from the People's Republic of China."

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts